EUVIMEDEUVIMED entdecken
Crossref

Top advances of the year: Gastroesophageal cancer

Ryan C Augustin iD, Zhaohui Jin, Harry H Yoon iD

Cancer · 01.06.2026 · 132 (11)

DOI: 10.1002/cncr.70471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 29.05.2026. Verfasst von Ryan C Augustin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in gastroesophageal cancer highlight the continued evolution of systemic therapy across disease stages, including refinements in perioperative strategies and expansion of biomarker‐directed treatment in advanced disease. Emerging therapeutic approaches, including next‐generation antibodies and combination strategies, are expected to further shape treatment selection and improve outcomes.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscombined modality therapyesophageal neoplasmsgastroesophageal junctionimmune checkpoint inhibitorsneoadjuvant therapyprecision medicinestomach neoplasmstumor

Autor:innen und Institutionen

  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Ryan C Augustin, Harry H Yoon

Zitieren

APA

Augustin, R. C., Jin, Z., & Yoon, H. H. (2026). Top advances of the year: Gastroesophageal cancer. Cancer, 132(11). https://doi.org/10.1002/cncr.70471

Vancouver

Augustin RC, Jin Z, Yoon HH. Top advances of the year: Gastroesophageal cancer. Cancer. 2026;132(11). doi:10.1002/cncr.70471

BibTeX
@article{Augustin2026,
  author = {Augustin, Ryan C and Jin, Zhaohui and Yoon, Harry H},
  title = {Top advances of the year: Gastroesophageal cancer},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {11},
  doi = {10.1002/cncr.70471}
}
Kostenlos starten →